Shearman & Sterling acted as counsel to the underwriters represented by Barclays Capital Inc. and J.P. Morgan Securities LLC in connection with the public offering of $300 million aggregate principal amount of 2.050% Senior Notes due 2014, $900 million aggregate principal amount of 3.200% Senior Notes due 2016 and $1 billion aggregate principal amount of 4.500% Senior Notes due 2021 of Thermo Fisher Scientific Inc. The proceeds of the offering will be used to finance Thermo Fisher's acquisition of Dionex Corporation. Thermo Fisher is a provider of analytical technologies and laboratory equipment, supply and services.

The Shearman & Sterling team included partners Michael Schiavone (New York-Capital Markets) and Bernie Pistillo (New York-Tax); counsel Jason Pratt (New York-Real Estate/Environmental); associates Joe M. Sasanuma (New York-Capital Markets), Michael Blankenship (New York-Financial Institutions Advisory & Financial Regulatory), Seth Kerschner (New York-Real Estate/Environmental), Derek Kershaw (New York-Tax), and Gloria Jung (New York-Intellectual Property Transactions); international associate Wolfram Prusko (New York-Financial Institutions Advisory & Financial Regulatory); and legal assistant Daniela Ritter (New York-Capital Markets).